Scancell doses first patient in melanoma-focused trials
26th Mar 2024 14:00
(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic. Read More
| Price | 9.55p on 19-04-2024 at 05:00:07 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Buy / Sell SCLP Shares | |
| Last Trade: | Buy 10,000.00 at 9.58p |
| Day's Volume: | 0 |
| Last Close: | 9.55p |
| Open: | 0.00p |
| ISIN: | GB00B63D3314 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 7.65p - 17.375p |
| Market Capitalisation: | £89m |
| VWAP: | 0.00p |
| Shares in Issue: | 929m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Recent Trades History Scancell Holdings (SCLP) |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 9.58p | Ordinary |
14:58:06 - 18-Apr-24 |
| Buy* | 104,324 | 9.57395p | Ordinary |
14:01:56 - 18-Apr-24 |
| Unknown* | 37,200 | 9.40p | Ordinary |
12:01:25 - 18-Apr-24 |
| Unknown* | 2,659 | 9.40p | Ordinary |
11:07:42 - 18-Apr-24 |
| Unknown* | 46,652 | 9.40p | Uncrossing Trade |
10:00:20 - 18-Apr-24 |
| Unknown* | 2,127 | 9.40p | Ordinary |
10:00:14 - 18-Apr-24 |
| Unknown* | 19,047 | 9.40p | Ordinary |
07:40:11 - 18-Apr-24 |
| Buy* | 5,000 | 9.412p | Ordinary |
07:16:58 - 18-Apr-24 |
| Buy* | 500 | 9.50p | SI Trade |
07:16:58 - 18-Apr-24 |
| Sell* | 19,009 | 9.325p | Ordinary |
07:16:42 - 18-Apr-24 |